A randomized, multicentric, comparative evaluation of aceclofenac- paracetamol combination with aceclofenac alone in Indian patients with osteoarthritis flare-up

Expert Opinion on Pharmacotherapy

Volumn 10, Issue 5, 2009, Pages 727-735

  Pareek, Anil ^a   Chandurkar, Nitin ^a   Sharma, V D ^b   Desai, Mohan ^c   Kini, Seema ^d   Bartakke, Girish ^e  

^a Ipca Laboratories Ltd   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

^c KEM HOSPITAL   (India)

^d BYL NAIR CHARITABLE HOSPITAL   (India)

^e B J MEDICAL COLLEGE   (India)

Author keywords

Aceclofenac; Aceclofenac paracetamol; Osteoarthritis flare up; Pain

Indexed keywords

ACECLOFENAC; PARACETAMOL;

ADULT; AGED; ANALGESIA; ARTHRALGIA; ARTICLE; CLINICAL EVALUATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; FEMALE; GASTRITIS; GENERALIZED EDEMA; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; NAUSEA; OPEN STUDY; OSTEOARTHRITIS; OUTCOME ASSESSMENT; PAIN ASSESSMENT; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SWELLING; VOMITING;

ACETAMINOPHEN; ADULT; AGED; DICLOFENAC; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; OSTEOARTHRITIS; PAIN MEASUREMENT;

EID: 67649610078     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656560902781931     Document Type: Article

References (32)

1. Boureau F, Schneid H, Zeghari N, et al. The IPSO study: ibuprofen, paracetamol study in osteoarthritis. A randomized comparative clinical study comparing the efficacy and safety of ibuprofen and paracetamol analgesic treatment of osteoarthritis of knee or hip. Ann Rheum Dis 2004;63:1028-1034
2. Goswami R, Mishra SK, Kochupillai N. Prevalence & potential significance of vitamin D deficiency in Asian Indians. Indian J Med Res 2008;127:229-238 (Pubitemid 351936149)
3. Sharma MK, Swami HM, Bhatia V, et al. An epidemiological study of correlates of osteo-arthritis in geriatric population of UT Chandigarh. Indian J Community Med 2007;32:1-3
4. Parek A, Chandanwale AS, Oak J, et al. Efficacy and safety of aceclofenacin the treatment of osteoarthritis: a randomized double blind comparative clinical trial versus diclofenac-an indian experience. Curr Med Res Opin 2006;22(5):977-988 (Pubitemid 43875567)
5. Hadler NM. Knee pain in the malady - not osteoarthritis [editorial]. Ann Intern Med 1992;116:598-599
6. Silverstein FE, Faich G, Goldstein JL, et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-Term Arthritis Safety Study. JAMA 2000;284:1247-1255 (Pubitemid 30691365)
7. Greenberg NJ. Update in gastroenterology. Ann Intern Med 1997;127:827-834 (Pubitemid 27465552)
8. Kehlet H, Dahl JB. The value of 'multimodal' or 'balanced analgesia' in postoperative pain treatment. Anaesth Analg 1993;77:1048-1056
9. Brandt KD, Bradley JD. Should the initial drug used to treat osteoarthritis pain be a nonsteroidal anti-inflammatory drug? [editorial]. J Rheumatol 2001;28:467-473 (Pubitemid 32202644)
10. Jordan KM, Arden NK, Doherty M, et al. EULAR recommendations 2003: an evidence-based approach to the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003;62:1145-1155 (Pubitemid 37500619)
11. Eccles M, Freemantle N, Mason J. North of England evidence based guideline for non-steroidal anti-inflammatory drugs versus basic analgesic in treating the pain of degenerative arthritis. The North of England Non-Steroidal Anti-inflammatory Drug Guideline Development Group BMJ 1998;317:526-530 (Pubitemid 28379610)
12. American college of rheumatology subcommittee on osteoarthritis guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. Arthritis Rheum 2000;43:1905-1915
13. Legrand E. Aceclofenac in the management of inflammatory pain. Expert Opin Pharmacother 2004;5:1347-1357 (Pubitemid 38885794)
14. Dooley M, Spencer CM, Dunn CJ. Aceclofenac: a reappraisal of its use in the management of pain and rheumatic disease. Drugs 2001;61:1351-1378 (Pubitemid 32744414)
15. Perez Busquier M, Calero E, Rodriguez M, et al. Comparison of aceclofenac with piroxicam in the treatment of osteoarthritis. Clin Rheumatol 1997;16:154-159 (Pubitemid 27119787)
16. Giorgianni G, Ottaviani C, Soliano A, et al. Efficacy and tolerability of aceclofenac versus ketoprofen in the treatment of rheumatoid arthritis. Curr Ther Res 1992;51:1-10
17. Batle-Gualda E, Figueroa M, Ivorra J, et al. The efficacy and tolerability of aceclofenac in the treatment of patients with ankylosing spondylitis: a multicentre controlled clinical trial. J Rheumatol 1996;23:1200-1206 (Pubitemid 26240586)
18. Miceli-Richard C, le Bars M. Paracetamol in osteoarthritis of the knee. Ann Rheum Dis 2004;63:923-930
19. Acetomaminophen (Systemic). Drug information for the health care professional. Twenty first edition. USPDI, Micromedex Thomson Healthcare. 2001:1:p. 8-9
20. Laurence DR, Bennett PN, Brown MJ. Individual NSAIDs. Eighth edition.In: Clinical pharmacology. Churchill Livingstone: London; 1997. p. 253, 260
21. Martindale - the complete drug reference Ed. Sean C Sweetman. Pharmaceutical Press:London; Thirty third edition. 2003. p. 73
22. Allerdyer C, Baarr L, Blake J, et al. Medicines compendium. Datapharm communication: London; 2002. p. 1594
23. Brogden RN, Wiseman LR. Aceclofenac. A review of its pharmacodynamic properties and therapeutic potential in the treatment of rheumatic disorders and in pain management. Drugs 1996;52:113-124
24. Lequesne MG. The algofunctional indices for hip and knee osteoarthritis. J Rheumatol 1997;24:779-781 (Pubitemid 27146100)
25. American college of rheumatology subcommittee on osteoarthritis guidelines. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 Update. Arthritis Rheum 2000;43:1905-1915
26. Coluzzi PH. Cancer pain management: newer perspectives on opioids and episodic pain. Am J Hosp Palliat Care 1998;15:13-22
27. Simmonds MA. Management of breakthrough pain due to cancer. Oncology 1999;13:1103-1108
28. Portenoy RK, Payne D, Jacobsen P. Break through pain: characteristics and impact in patients with cancer pain. Pain 1999;81:129-134 (Pubitemid 29199908)
29. Scott-Lennox JA, McLaughlin-Miley C, Lennox RD, et al. Stratification of flare intensity identifies placebo responders in a treatment efficacy trial of patients with osteoarthritis arthritis & rheumatism. Am Coll Rheumatol 2001;44:1599-1607 (Pubitemid 32642222)
30. McConnell S, Kolopack P, Davis AM. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC): a review of its utility and measurement properties. Arthritis Rheum 2001;45:453-461 (Pubitemid 32979851)
31. Ehrich EW, Davies GM, Warson DJ, et al. Minimal perceptible clinical improvement with the Western Ontario and McMaster Universities Osteoarthritis Index questionnaire and global assessments in patients with osteoarthritis. J Rheumatol 2000;27:2635-2641 (Pubitemid 30847940)
32. Batlle-Gualda E, Roman Ivorra J, Carbonell J, et al. Aceclofenac vs paracetamol in the management of symptomatic osteoarthritis of the knee: a double-blind 6-week randomized controlled trial. Osteoarthritis Cartilage 2007;15:900-908 (Pubitemid 47209253)